March 28, 2025
Office of The Director, National Institutes of Health (OD)
On January 10, 2025, NIH issued the Intramural Research Program (IRP) Access Planning Policy (NOT-OD-25-062) requiring organizations applying to NIH for certain commercial patent licenses to submit access plans to NIH outlining steps they intend to take to promote patient access to those licensed products. The IRP Access Planning Policy applies to license applications and licenses granted by the NIH IRP for patents wholly owned by the government.
The NIH is committed to working with organizations to ensure successful implementation of this Policy. As such, NIH is delaying the effective date to accommodate further stakeholder outreach discussion in developing meaningful access approaches and incentive for partnerships. The Policy will now apply to license applications submitted to NIH on or after October 1, 2025.
Please direct all inquiries to:
NIH Office of Science Policy